Review

insulin (R&D Systems)

R&D Systems is a verified supplier

R&D Systems manufactures this product

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

R&D Systems insulin
Insulin, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 30 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+apo+transferrin/Human+Apo-Transferrin+Protein%2C+CF/pm41533509-727-74-71
Average 94 stars, based on 30 article reviews

insulin - by Bioz Stars, 2026-10

94/100 stars

Images

Modification:

Article Title: Cytotoxicity assay using a human pluripotent stem cell-derived cranial neural crest cell model.
Article Snippet: Cleft lip and palate are the most common congenital abnormalities that occur early in pregnancy.. The majority of cranial mesenchyme is derived from cranial neural crest cells that differentiate into odontoblasts, cartilage, craniofacial bone, and connective tissue.. A subset of these cells differentiates into cranial ganglia.

Knock-Out:

Article Title: DUX4 Transcript Knockdown with Antisense 2'-O-Methoxyethyl Gapmers for the Treatment of Facioscapulohumeral Muscular Dystrophy.
Article Snippet: For growing cells, a growth medium was prepared with 15% fetal bovine serum (FBS) (Sigma, St. Louis, MO), 0.055 μg/ml dexamethasone, 2.5 ng/ml recombinant human hepatocyte growth factor (EMD Millipore, Burlington, MA), and 10 ng/ml recombinant human fibroblast growth factor (BioPioneer, San Diego, CA) in basal medium (BM; 20% Medium 199 [Life Technologies, Carlsbad, CA], 0.03 μg/ml ZnSO4, 1.4 μg/ml vitamin B12, and 2.5% penicillinstreptomycin in DMEM [Life Technologies]). .. For differentiation, the following was prepared: 15% KnockOut Serum Replacement (KOSR; Life Technologies),47 10 μg/ml insulin (Sigma), Jo urn al Pr e-p roo f 15 and 100 μg/ml human apo-transferrin (R&D Systems, Minneapolis, MN) in BM. ..

other:

Article Title: Direct conversion of human umbilical cord mesenchymal stem cells into dopaminergic neurons for Parkinson's disease treatment.
Article Snippet: hUCMSCs at passages 3 to 6 were seeded at a density of 1 × 104 cells/ cm2 in α-MEM supplemented with 10 % FBS, and the neuron induction medium, comprising DMEM/F12 (Corning), 0.5 % penicillin/streptomycin (HyClone), 1 mM sodium pyruvate (Solarbio), 50 μg/ml human apo-transferrin (R&D Systems), 25 μg/ml insulin (Yeason), 0.5 % B27 (Gibco), 100 nM putrescine (Sigma-Aldrich), 30 nM sodium selenite (Sigma-Aldrich), 20 nM progesterone (Sigma-Aldrich), 20 ng/ml BDNF (PeproTech), 20 ng/ml NT3 (PeproTech), 5 μM Y27632 (Selleck), 50 μM Forskolin (Selleck), 2 μM SB431542 (Selleck), and 10 μM SP600125 (Selleck), was replaced 24 h later, with subsequent medium changes every 3 days.